Cancer Cell International

雜志介紹

Cancer Cell International雜志介紹

《Cancer Cell International》是一本以English為主的開放獲取國際優秀期刊，中文名稱國際癌細胞，本刊主要出版、報道醫學-ONCOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為5.3，最新CiteScore 指數為10.9。

本刊近期中國學者發表的論文主要有：

• Combination therapy with oncolytic viruses and immune checkpoint inhibitors in head and neck squamous cell carcinomas: an approach of complementary advantages

  Author: Dong, Hui; Li, Mengli; Yang, Chen; Wei, Wei; He, Xianglei; Cheng, Gang; Wang, Shibing

• Heat shock protein 27 deficiency promotes ferrous ion absorption and enhances acyl-Coenzyme A synthetase long-chain family member 4 stability to promote glioblastoma cell ferroptosis

  Author: Zhang, Kai; Wu, Yue; Chen, Guangliang; Wang, Hao; Liu, Yongsheng; Zhou, Youxin

• Long noncoding RNAs: glycolysis regulators in gynaecologic cancers

  Author: Lv, Nengyuan; Shen, Siyi; Chen, Qianying; Tong, Jinyi

• RGS proteins and their roles in cancer: friend or foe?

  Author: Li, Lin; Xu, Qiang; Tang, Chao

英文介紹

Cancer Cell International雜志英文介紹

Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques.

The journal focuses on novel cancer studies reporting data from biological experiments performed on cells grown in vitro, in two- or three-dimensional systems, and/or in vivo (animal experiments). These types of experiments have provided crucial data in many fields, from cell proliferation and transformation, to epithelial-mesenchymal interaction, to apoptosis, and host immune response to tumors.

Cancer Cell International also considers articles that focus on novel technologies or novel pathways in molecular analysis and on epidemiological studies that may affect patient care, as well as articles reporting translational cancer research studies where in vitro discoveries are bridged to the clinic. As such, the journal is interested in laboratory and animal studies reporting on novel biomarkers of tumor progression and response to therapy and on their applicability to human cancers.